Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
BioNTech AG
BioNTech AG
Activities:
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Overcoming CMC challenges in cell and gene therapy: part I
Certara’s Dr Hien Anh Bruno, Associate Director, Chemistry, Manufacturing and Controls (CMC), and Dr Deven Shah, CMC Lead, propose mitigation strategies to address the CMC...
Resolving capping issues in tablet manufacturing
Natoli explores the various causes of capping and the methods to prevent it
Effective ways to optimise heat exchangers
Heat exchangers are used within a wide range of process industries as a way to transfer heat between two fluid streams across a medium in an energy conservative way
Transforming healthcare with patient centricity
In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Finance
BioNTech and Autolus announce strategic collaboration
The strategic collaboration will advance both companies' autologous CAR-T programmes towards commercialisation, pending regulatory authorisations
Manufacturing
AGC to support Pfizer-BioNTech Omicron vaccine
Plasmid DNA from AGC is already supplied as a starting material for the companies' COVID-19 vaccine
Ingredients
Pfizer and BioNTech announce early positive vaccine update
Collaboration has announced results from German Phase 1/2 COVID-19 vaccine study, including first T-Cell response data
Finance
BioNTech completes acquisition of Neon Therapeutics
Biopharmaceutical New Technologies (BioNTech) is a next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases
Research & Development
BioNTech and Pfizer dose first cohort of Phase I/II COVID-19 vaccine trial
The trial is the first clinical trial of a COVID-19 vaccine candidate in Germany and there are plans to initiate trials in the US upon regulatory approval
Research & Development
Sanofi and BioNTech sign cancer immunotherapy partnership
BioNTech could receive more than US$300m in development, regulatory and commercial milestones
Research & Development
BioNTech and Siemens cooperate on production of personalised cancer vaccines
Siemens will develop and construct an automated and paperless manufacturing site
Subscribe now